the aid library

LIST OPTIONS

Filter

7638

Sort by:

Direction:

Download (95)

View PDF (55)

Hypertension in adults: diagnosis and management

the National Institute for Health and Care Excellence (NICE) the National Institute for Health and Care Excellence (NICE) (2023) CC

The NICE guideline "Hypertension in Adults: Diagnosis and Management" outlines recommendations for diagnosing and managing hypertension in adults over 18, including those with type 2 diabetes. It emphasizes accurate blood pressure measurement, recommending ambulatory or home monitoring to confirm di... more

Download (159)

View PDF (1043)

Protection Against Sexual Exploitation and Abuse, Multi-Year Strategy for Ukraine 2023-25
recommended

UN Country Team in Ukraine (2023) CC

The purpose of this multi-year strategy is to guide the strategic direction for the collective work of the Protection against Sexual Exploitation and Abuse (PSEA) Programme in Ukraine. It replaces the 2017 HCT Framework on PSEA in Ukraine, incorporates the priorities set by the IASC Vision and Strat... more

Download (152)

View PDF (188)

Good practice statement on the use of variant-containing COVID-19 vaccines

World Health Organization WHO (2022) C_WHO

Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-... more

Download (109)

View PDF (153)

Indoor air quality at home

National Institute for Health and Care Excellence (NICE) (2020) C2

This guideline covers indoor air quality in residential buildings. It aims to raise awareness of the importance of good air quality in people's homes and how to achieve this.

Download (91)

View PDF (1150)

The global threat of antibiotic resistance

ReAct (2019) C2

A short movie about the history and the current status of antibiotics from the four week online course: Antibiotic Resistance: the silent tsunami, produced by ReAct and Uppsala University, Sweden.

Download (285)

View PDF (288)

ICO Guidelines for Diabetic Eye Care

Interntaional Council of Opthalmology ICO (2017) C1

Updated 2017

Download (752)

View PDF (1292)

Zika Virus Research Agenda - October 2016

World Health Organization WHO (2016) C_WHO

Download (270)

View PDF (518)

Mental health problems in people with learning disabilities

National Institute for Health and Care Expericen (NICE) (2016) C1

Prevention, Assessment and Management

Download (1449)

View PDF (3186)

I See That It Is Possible - Gender-based Violence Disability Toolkit
recommended

Women's Refugee Commission, et al. (2015) C1

This toolkit is intended to support GBV staff to build disability inclusion into their work, and to strengthen the capacity of GBV practitioners to use a survivor-centered approach when providing services to survivors with disabilities. The tools are designed to complement existing guidelines, prot... more

Download (382)

View PDF (190)

Life and dignity of the human person, Country spotlight: Vietnam

Catholic Relief Service CRS (2015) CC

The principle Life and Dignity of the Human Person is one of the seven themes of Catholic social teaching (United States Conference of Catholic Bishops) . We believe that God created man and woman in his image (Genesis 1:26–27) and because of this all people have inherent dignity . There is nothin... more

Download (137)

View PDF (169)

Solidarity - Country Spotlight Democratic Republic of Congo

Catholic Relief Services CRS (2015) C1

Lesson Plans grades 1–8

Download (241)

View PDF (428)

Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy

World Health Organization WHO (2013) C_WHO

New criteria for classifying and diagnosing hyperglycaemia first detected during pregnancy have been accepted by a group of experts convened by WHO. These new criteria are an update of recommendations published by WHO in 1999

Download (291)

View PDF (508)

Manual on Flood: Causes, Effects & Preparedness

The Republic of the Union of Myanmar, Relief and Resettlement Department; UN-Habitat (2010) C1

No publication year indicated.

Download (280)

View PDF (375)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (167)

View PDF (156)

Learning Modules. COVID-19 Vaccines in Pregnancy and Safe Breastfeeding

Pan American Health Organization (PAHO) (2023) C_WHO

This is an e-learning module with the objective of providing education for health professionals and pregnant women using published results and studies based on COVID-19 surveillance data, which have indicated an increased risk among pregnant women of presenting with severe forms of COVID-19 and, the... more

Download (114)

View PDF (159)

Interim recommendations for heterologous COVID-19 vaccine schedules

World Health Organization WHO (2021) C_WHO

Overview 16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).

Download (952)

View PDF (1297)

Tips for Lowering pharmacy Temperatures To maintain good medicine Quality

USAID, SIAPS (2014) CC

Accessed July 2014

Download (135)

View PDF (139)

RMRP 2020 - Regional Refugee and Migrant Response Plan for Refugees and Migrants from Venezuela 2020

R4V; reliefweb (2020) C2

The Venezuelan refugee and migrant crisis is one of the biggest external displacement crises in the world today. The COVID-19 pandemic has compounded an already desperate situation for many refugees and migrants, as well as their hosts, sorely testing health and social welfare systems and the abilit... more

Download (293)

View PDF (723)

Myanmar refugee emergency response in Bangladesh: Supplementary appeal March - December 2018

UN High Commissioner for Refugees (2018) C1

Download (79)

View PDF (140)

Interim Briefing Note - Addressing Mental Health and Psychosocial Aspects of COVID-19 Outbreak - Version 1.5

IASC Reference Group on Mental Health and Psychosocial Support in Emergency Settings; OCHA Services (2020) C2

February 2020

Protection Against Sexual Exploitation and Abuse, Multi-Year Strategy for Ukraine 2023-25 recommended

I See That It Is Possible - Gender-based Violence Disability Toolkit recommended

Protection Against Sexual Exploitation and Abuse, Multi-Year Strategy for Ukraine 2023-25
recommended

I See That It Is Possible - Gender-based Violence Disability Toolkit
recommended